Nathalie Moll, EFPIA Director General (EFPIA)
Pharma firms make new pledge to launch in all Euro markets at least 2 years post-authorization
As part of a drive to increase new meds across Europe, member companies of the continent’s largest pharma lobbying organization have set a new goal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
